EN
ページタイトル画像

Neurological Surgery

Overview

Department of Neurological Surgery maintains an active clinical service , educations, and researches. We provide leading-edge technologies for complex conditions in the following areas: cerebrovascular diseases, gliomas and other malignant brain tumors, sellar and parasellar lesions, skull base tumors, spinal disease, and neuronal function disorders. Our patients can have access to less-invasive surgical procedures and the most novel therapies. We also offer an excellent training program in neurosurgery for neurosurgical residents, in cooperation with other related hospitals and medical. centers.

Professor:
Yasuo Iwadate, M.D., Ph.D.

TEL: +81-43-226-2158
FAX: +81-43-226-2159
e-mail:iwadatey●faculty.chiba-u.jp
URL: https://www.m.chiba-u.ac.jp/dept/neurosurgery/

※　Please change "●" mark to at-mark if you send emails.

07.jpg

Research & Education

07図.jpg

We focus on the following research areas:

  1. Serum autoantibody markers for cerebral infarction
  2. Serum autoantibody markers for gliomas
  3. Diagnosis and treatment of malignant brain tumors
  4. Immune-related therapy for glioblastoma
  5. Endovascular treatment for cerebral aneurysms
  6. Diagnosis and treatment of sellar and parasellar lesions
  7. Endoscopic surgery for various intracranial lesions
  8. Carotid artery stenting
  9. Surgical treatment for movement disorders
  10. Epilepsy surgery
  11. Treatment of spinal spondylosis and spinal cord tumors
  12. Mechanisms of neurovascular compression syndromes

Recent Publications

  1. Hiwasa T, Wang H, Goto KI, Mine S, Machida T, Kobayashi E, Yoshida Y, Adachi A, Iwadate Y, et al. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. BMC Med 2021;19: 131.
  2. Higuchi Y, Ikegami S, Horiguchi K, Aoyagi K, Nagano O, Serizawa T, Tajima Y, Hanazawa T, Yamakami I, Iwadate Y. Predicting Potential of Rapid Tumor Growth in Small to Medium Vestibular Schwannomas on the Basis of Sway Assessed Using Posturography. World Neurosurg. 2021; 148: e406-e414.
  3. Hara A, Koyama-Nasu R, Takami M, Toyoda T, Aoki T, Ihara F, Kobayashi M, Hirono S, Matsutani T, Nakayama T, Iwadate Y, Motohashi S. CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Cancer Immunol Immunother. 2021; 70: 1239-1254.
  4. Jitsuishi T, Hirono S, Yamamoto T, Kitajo K, Iwadate Y, Yamaguchi A. White matter dissection and structural connectivity of the human vertical occipital fasciculus to link vision-associated brain cortex. Sci Rep 2020; 10: 820.